CompoAtlas

菱山優智綜合錠狀食品

菱山優智綜合錠狀食品 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

Registration number
1110612621
Chinese name
菱山優智綜合錠狀食品
English name
NEW HISHIYAMA EXP TABLETS
Type
Imported tablets and capsules
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
德效國際有限公司
Registration date
2022-12-21
Published validity end
2027-12-21

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
CASEIN CALCIUMCASEIN CALCIUMCalcium
D-LACTOSED-LACTOSENot identified
SOY PROTEIN POWDERSOY PROTEIN POWDERNot identified
ORANGE FLAVORORANGE FLAVORNot identified
VITAMIN C (ASCORBIC ACID)VITAMIN C (ASCORBIC ACID)Vitamine C
VITAMIN B1 (THIAMINE MONONITRATE)VITAMIN B1 (THIAMINE MONONITRATE)Vitamine B1 (thiamine)
VITAMIN B2 (RIBOFLAVIN)VITAMIN B2 (RIBOFLAVIN)Vitamine B2 (riboflavine)
VITAMIN B6 (PYRIDOXINE HCL)VITAMIN B6 (PYRIDOXINE HCL)Vitamine B6
VITAMIN B12 (CYANOCOBALAMIN)VITAMIN B12 (CYANOCOBALAMIN)Vitamine B12
FRUCTOOLIGOSACCHARIDESFRUCTOOLIGOSACCHARIDESNot identified
CHITOSANCHITOSANChitosan
CRYPTHECODINIUM COHNIICRYPTHECODINIUM COHNIINot identified
BETA-CAROTENEBETA-CAROTENEBêta-carotène
BIFIDOBACTERIUM LACTISBIFIDOBACTERIUM LACTISNot identified
VITAMIN D3 (CHOLECALCIFEROL)VITAMIN D3 (CHOLECALCIFEROL)Vitamine D
MICROCRYSTALLINE CELLULOSEMICROCRYSTALLINE CELLULOSENot identified
MAGNESIUM STEARATEMAGNESIUM STEARATENot identified
STEARIC ACIDSTEARIC ACIDAcide stéarique
TITANIUM DIOXIDETITANIUM DIOXIDENot identified
BEET RED COLORBEET RED COLORNot identified
SAFFLOWER YELLOW COLORSAFFLOWER YELLOW COLORNot identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Original register data

View published fields and their variants
Product name
菱山優智綜合錠狀食品
Active ingredients
CASEIN CALCIUM;;D-LACTOSE;;SOY PROTEIN POWDER;;ORANGE FLAVOR;;VITAMIN C (ASCORBIC ACID);;VITAMIN B1 (THIAMINE MONONITRATE);;VITAMIN B2 (RIBOFLAVIN);;VITAMIN B6 (PYRIDOXINE HCL);;VITAMIN B12 (CYANOCOBALAMIN);;FRUCTOOLIGOSACCHARIDES;;CHITOSAN;;CRYPTHECODINIUM COHNII;;BETA-CAROTENE;;BIFIDOBACTERIUM LACTIS;;VITAMIN D3 (CHOLECALCIFEROL);;MICROCRYSTALLINE CELLULOSE;;MAGNESIUM STEARATE;;STEARIC ACID;;TITANIUM DIOXIDE;;BEET RED COLOR;;SAFFLOWER YELLOW COLOR;;
Valid until
1161221
Registration number
1110612621
Licence holder
德效國際有限公司
Registration date
1111221
Published reference
DHC0B106126216
Published English name
NEW HISHIYAMA EXP TABLETS

Official source

View the official register, number 1110612621

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • CHITOSAN
    Read the warning, when it applies and the studies cited

    CHITOSAN

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (Pittler et al. 1999).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Condition of application: All products (except for weight management).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: Weight management.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.

    Contraindications

    Condition of application: All products.

    Do not use if you have an allergy to seafood.

    Condition of application: Weight management.

    Do not use if you are pregnant (HC 2010).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    When using this product you may experience gastrointestinal discomfort/disturbances (Moraru et al. 2018; Mhurchu et al. 2004; Pittler et al. 1999).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 November 2024

  • VITAMIN D3 (CHOLECALCIFEROL)
    Read the warning, when it applies and the studies cited

    VITAMIN D (>1,000 - 2,500 IU)

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products except products containing zinc sourced from picolinate requiring a contraindication.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.

    Applies to products containing vitamin K2.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Condition of application: All products.

    Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products containing zinc sourced from picolinate.

    Do not use if you are pregnant or breastfeeding (NNHPD 2026).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: All products.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products providing more than 350 mg of magnesium per day.

    When using this product you may experience diarrhea (NNHPD 2026).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 26 June 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line